Related Experiment Video
Updated: Feb 2, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case-control
Zhi Jian Wang1, Jie Chen2, Hai Liang Chen1
1Department of Neurology, Fuzhou Neuropsychiatry Hospital, Fujian 350008, China.
Insights
Valproic acid (VPA) resistance in children is a growing concern. The TT genotype of the SCN1A rs3812718 polymorphism increases the risk of VPA resistance, while the recessive model may decrease it.
Area of Science:
- Genetics
- Pharmacogenomics
- Epilepsy Research
Background:
- Valproic acid (VPA) is a primary antiepileptic drug (AED) with increasing resistance rates, especially in pediatric epilepsy.
- Genetic factors, particularly single nucleotide polymorphisms (SNPs), are implicated in VPA resistance.
- The SCN1A gene, encoding a voltage-gated sodium channel, is a potential candidate for influencing drug response.
Purpose of the Study:
- To investigate the association between the SCN1A polymorphism rs3812718 and valproic acid (VPA) resistance in children with epilepsy.
- To determine if specific genotypes of rs3812718 confer a higher risk of VPA resistance.
- To conduct a meta-analysis to strengthen the findings on voltage-gated sodium channel gene polymorphisms and drug resistance.
Main Methods:
- A cohort of 231 children with epilepsy, treated solely with VPA, was studied.
- DNA was extracted from blood samples and genotyped using the Mass Array method for the SCN1A rs3812718 polymorphism.
- A meta-analysis was performed, combining data from this study with existing literature on drug-responsive and resistant epilepsy patients exposed to voltage-gated sodium channels.
Main Results:
- The TT genotype of the SCN1A rs3812718 polymorphism was significantly associated with an increased risk of VPA resistance (OR = 2.636, P = 0.033).
- This association remained significant after adjusting for risk factors (OR = 2.861, P = 0.025).
- The recessive genetic model for this polymorphism was linked to a decreased risk of VPA resistance after risk factor adjustment (OR = 0.402, P = 0.042).
- Meta-analysis of nine studies corroborated these findings, indicating a consistent association.
Conclusions:
- The rs3812718 TT genotype is a significant risk factor for developing valproic acid resistance in children with epilepsy.
- The recessive genetic model of the SCN1A rs3812718 polymorphism may offer a protective effect against VPA resistance.
- These findings highlight the role of SCN1A genetic variations in VPA treatment outcomes and suggest potential for personalized epilepsy management.
Abstract:
Resistance to valproic acid (VPA), a first-line antiepileptic drug (AED), is occurring at an alarming rate, particularly in children. Signal nucleotide polymorphisms are considered crucial in this process. Therefore, we investigated whether the SCN1A polymorphism rs3812718 could be associated with VPA resistance. A total of 231 children with epilepsy who were solely administered VPA were enrolled. DNA was extracted from the peripheral blood samples and was genotyped by the Mass Array method. Furthermore, a meta-analysis was conducted between the drug responsive and resistant patients who were exposed to voltage-gated sodium channels. Results revealed that the TT genotype was associated with a higher risk of developing drug resistance (OR = 2.636, 95% CI 1.08-6.433, P = 0.033). After adjusting for the risk factors, a significant difference was still observed between the responsive and resistant groups (OR = 2.861, 95% CI 1.141-7.174, P = 0.025). Moreover, the recessive model was associated with a decreased drug resistance (OR = 0.402, 95% CI 0.167-0.968, P = 0.042) after correcting the risk factors. Meta-analysis of nine studies revealed similar results. In conclusion, our results proved that the rs3812718 TT genotype was associated with a high risk of developing drug resistance, and the recessive model could decrease the risk of VPA resistance.
More Related Videos
09:32Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
06:26Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
Published on: November 27, 2019
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Directing Effect of Substituents: meta-Directing Groups
Amino acids
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Associative Learning
Classical conditioning, also known...